Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Fimmg, officially the Finnish Medicines Agency (Lääkealan turvallisuus- ja kehittämiskeskus Fimea), is the national competent authority for regulating pharmaceuticals, medical devices, blood and tissue products, and biobanks in Finland. Its mission is to promote the health and safety of the population by ensuring the efficacy, safety, and quality of medicines and healthcare products, and by advancing their appropriate use. Fimmg operates under the Ministry of Social Affairs and Health and plays a crucial role in pharmacovigilance, market surveillance, licensing, and providing information to healthcare professionals and the public.
The Helsinki headquarters serves as the central administrative and regulatory hub, overseeing national pharmaceutical licensing, inspections, safety monitoring, and international collaboration. It houses most of Fimmg's core operational departments.
Modern office facilities equipped to support scientific assessment, regulatory work, and administrative functions. Located strategically for accessibility and collaboration with other governmental and health organizations.
As a government regulatory agency, the work culture at Fimmg is characterized by professionalism, scientific rigor, impartiality, and a strong commitment to public health and safety. Collaboration and expertise are highly valued.
The headquarters is pivotal for the Finnish healthcare system, ensuring that all medicines and medical devices available to the Finnish population meet stringent safety and efficacy standards. It's the nerve center for pharmaceutical regulation in the country.
As Finland's national regulatory authority, Fimmg actively participates in the European medicines regulatory network. This includes collaboration with the European Medicines Agency (EMA), the Heads of Medicines Agencies (HMA), and other national competent authorities across the European Economic Area. Fimmg contributes to joint assessments, inspections, and policy development, ensuring harmonized standards and sharing expertise internationally to promote public health globally.
Mannerheimintie 103b (visiting address for Helsinki)
Helsinki
Uusimaa
Finland
Address: Microkatu 1, 70210 Kuopio (P.O. Box 55, FI-00034 FIMEA)
Serves as a key operational site, leveraging regional expertise, particularly from the University of Eastern Finland and Kuopio University Hospital, and ensures Fimea's services are distributed beyond the capital region.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Libero Professionista' leadership includes:
Libero Professionista has been backed by several prominent investors over the years, including:
Specific high-profile executive changes at Fimmg are not frequently publicized unless involving the Director General or significant restructuring. Routine internal promotions or role changes within the directorship may occur without widespread public announcement. No major Director-level changes widely reported in the last 12 months.
Discover the tools Libero Professionista uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Fimmg, like many Finnish government agencies, typically uses a standardized email format. The most common format is firstname.lastname@fimea.fi.
firstname.lastname@fimea.fi
Format
matti.meikalainen@fimea.fi
Example
90%
Success rate
Fimea.fi • June 4, 2024
Fimea is organizing an information event for stakeholders on June 12, 2024, regarding the reform of the EU's pharmaceutical legislation. The event aims to discuss the key proposals and their potential impacts....more
Fimea.fi • May 28, 2024
The Finnish Medicines Agency (Fimea) has updated its guideline concerning the fees payable for its services. The updated guideline provides details on various regulatory service fees and their application....more
Fimea.fi • April 26, 2024
Fimea has issued a reminder to marketing authorisation holders about the importance of complying with sunset clause obligations to ensure continuous availability of medicines....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Libero Professionista, are just a search away.